BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1882740)

  • 1. Generalized seizure after i.v. administration of gadopentetate dimeglumine.
    Harbury OL
    AJNR Am J Neuroradiol; 1991; 12(4):666. PubMed ID: 1882740
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
    Tishler S; Hoffman JC
    AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 4. Anaphylactic shock induced by intravenous gadopentetate dimeglumine.
    Tardy B; Guy C; Barral G; Page Y; Ollagnier M; Bertrand JC
    Lancet; 1992 Feb; 339(8791):494. PubMed ID: 1346846
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential neurotoxic effects of gadopentetate dimeglumine: clinical significance.
    Alhassan A; Weinmann HJ
    AJNR Am J Neuroradiol; 1997 Apr; 18(4):785-6; author reply 786-8. PubMed ID: 9127052
    [No Abstract]   [Full Text] [Related]  

  • 6. Laryngospasm after administration of gadopentetate dimeglumine.
    Omohundro JE; Elderbrook MK; Ringer TV
    J Magn Reson Imaging; 1992; 2(6):729-30. PubMed ID: 1446118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine.
    García N; Ramón E; Gonzalez del Valle L; Ruano M; Jiménez E
    Ann Pharmacother; 1997 Mar; 31(3):374. PubMed ID: 9066954
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatal reaction to gadopentetate dimeglumine.
    Jordan RM; Mintz RD
    AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats.
    Mühler A; Saeed M; Brasch RC; Higgins CB
    Radiology; 1992 May; 183(2):523-8. PubMed ID: 1561362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical safety of gadopentetate dimeglumine.
    Nelson KL; Gifford LM; Lauber-Huber C; Gross CA; Lasser TA
    Radiology; 1995 Aug; 196(2):439-43. PubMed ID: 7617858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe adverse reaction to iv gadopentetate dimeglumine.
    Takebayashi S; Sugiyama M; Nagase M; Matsubara S
    AJR Am J Roentgenol; 1993 Mar; 160(3):659. PubMed ID: 8430574
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety review of gadopentetate dimeglumine. Extended clinical experience after more than five million applications.
    Niendorf HP; Alhassan A; Geens VR; Clauss W
    Invest Radiol; 1994 Jun; 29 Suppl 2():S179-82. PubMed ID: 7928222
    [No Abstract]   [Full Text] [Related]  

  • 13. Eye and testicular pain after administration of gadopentetate dimeglumine.
    Padhani AR; Lopez AJ; Revell PB; MacVicar DA
    AJR Am J Roentgenol; 1995 Aug; 165(2):484-5. PubMed ID: 7618587
    [No Abstract]   [Full Text] [Related]  

  • 14. [Artificial contrasting during magnetic resonance tomography].
    Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
    Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
    [No Abstract]   [Full Text] [Related]  

  • 15. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
    Witte RJ; Anzai LL
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):523-4. PubMed ID: 8197951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
    Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T
    AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
    [No Abstract]   [Full Text] [Related]  

  • 17. Dosage of gadoteridol and adverse reactions relative to gadopentetate.
    Hieronim DE; Kanal E; Swanson DP
    Am J Health Syst Pharm; 1995 Nov; 52(22):2556-9. PubMed ID: 8590239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findings.
    Roman-Goldstein SM; Barnett PA; McCormick CI; Ball MJ; Ramsey F; Neuwelt EA
    AJNR Am J Neuroradiol; 1991; 12(5):885-90. PubMed ID: 1950917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of gadodiamide injection and gadopentetate dimeglumine in anesthetized dogs.
    Peters JL; Shaw DD
    Acta Radiol; 1993 Sep; 34(5):510-6. PubMed ID: 8369191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gadolinium-DTPA dimeglumine administered orally for the study of the abdomen with magnetic resonance. Clinical evaluation and tolerance].
    Squillaci E; Crecco M; Cecconi L; Lupoi D; Sergiacomi GL; Simonetti G
    Radiol Med; 1993 Sep; 86(3):284-93. PubMed ID: 8210538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.